MarketScreener Homepage > Equities > NASDAQ OMX COPENHAGEN > Novozymes A/S NZYM B DK0060336014

Report

Real-time Estimate Cboe Europe - 01/27 10:59:45 am
376.6	DKK		+0.43%

10:16a

NOVOZYMES A/S : New enzyme helps producers of vital wheat gluten get more out of their wheat

01/08

NOVOZYMES A/S : completes acquisition of Microbiome Labs

01/05

NOVOZYMES A/S : New enzyme makes high protein drinks taste better

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq Omx Copenhagen

01/21/2021	01/22/2021	01/25/2021	01/26/2021	01/27/2021	Date
360.7(c)	356.6(c)	375.9(c)	375(c)	376.6(c)	Last
440 405	341 650	805 136	940 626	771 414	Volume
+0.56%	-1.14%	+5.41%	-0.24%	+0.43%	Change

More quotes

Financials

Sales 2020	14 097 M 2 295 M 2 295 M
Net income 2020	2 868 M 467 M 467 M
Net Debt 2020	4 292 M 699 M 699 M
P/E ratio 2020	36,9x
Yield 2020	1,45%

Sales 2021	14 545 M 2 368 M 2 368 M
Net income 2021	3 000 M 489 M 489 M
Net Debt 2021	4 813 M 784 M 784 M
P/E ratio 2021	34,8x
Yield 2021	1,53%

Capitalization	106 B 17 171 M 17 185 M
EV / Sales 2020	7,79x
EV / Sales 2021	7,59x
Nbr of Employees	6 180
Free-Float	71,9%

More Financials

Company

Novozymes AS is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market are as follows: - domestic cleaning and servicing products industry (33.1%); - food industry (29%); - bioenergy (19.6%); - agriculture and animal feed industry (13.1%): enzymes used to improve the productivity and digestion of foods; - wastewater treatment and technical industry (5.

Sector

Specialty Chemicals

Calendar

02/02

Earnings Release

More about the company

Notations Surperformance© of Novozymes A/S

Trading Rating :

Investor Rating :

More Ratings

All news about NOVOZYMES A/S

10:16a	NOVOZYMES A/S : New enzyme helps producers of vital wheat gluten get more out of..	PU
01/08	NOVOZYMES A/S : completes acquisition of Microbiome Labs	AQ
01/05	NOVOZYMES A/S : New enzyme makes high protein drinks taste better	PU
2020	NOVOZYMES A/S : acquires Microbiome Labs and adds a strong position in the North..	PU
2020	NOVOZYMES A/S : acquires Microbiome Labs	AQ
2020	NOVOZYMES A/S : switches to renewable electricity in North America	PU
2020	NOVOZYMES A/S : New sales reporting structure introduced. 2020 organic sales gro..	AQ
2020	NOVOZYMES A/S : New bioenergy enzyme solution harnesses the untapped potential o..	PU
2020	NOVOZYMES A/S : New biological solution strengthens gluten and improves dough	PU
2020	NOVOZYMES A/S : Proposal of candidates to the Board of Directors	AQ
2020	NOVOZYMES A/S : Change of management	AQ
2020	Givaudan Joins Novozymes to Discover New Sustainable Ingredients for Customer..	MT
2020	NOVOZYMES A/S : Trading by management and close relations of management	AQ
2020	NOVOZYMES A/S : Interim report for the first nine months of 2020	AQ
2020	NOVOZYMES A/S : Nomination	CO

More news

News in other languages on NOVOZYMES A/S

01/25	Apple, LVMH et Tesla au (copieux) menu de la semaine
01/25	AVIS D'ANALYSTES DU JOUR : Aperam, ArcelorMittal, CD Projekt, Imerys, Leoni, Nov..
01/06	Du rififi aux Etats-Unis pour l'Epiphanie
2020	L'indice à suivre pour changer du Nasdaq
2020	AVIS D'ANALYSTES DU JOUR : Adecco, Arkema, ASML, LafargeHolcim, Soltec, Superdry..

More news

Analyst Recommendations on NOVOZYMES A/S

2018	European shares recover from seven-day losing streak	RE
2018	European shares recover from seven-day losing streak	RE
2017	European shares retreat as Pearson plummets	RE

More recommendations

Provided by Scoopnest.com

Chart NOVOZYMES A/S

Duration : Period :

Novozymes A/S Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends NOVOZYMES A/S

	Short Term	Mid-Term	Long Term
Trends	Bullish	Neutral	Bullish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	UNDERPERFORM
Number of Analysts	19
Average target price	354,94 DKK
Last Close Price	376,60 DKK
Spread / Highest target	22,1%
Spread / Average Target	-5,75%
Spread / Lowest Target	-24,9%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Ester Baiget	President & Chief Executive Officer
Jørgen Buhl Rasmussen	Chairman
Graziela Chaluppe dos Santos Malucelli	Chief Operating Officer & Executive VP
Lars Green	Chief Financial Officer & Executive Vice President
Claus Crone Fuglsang	Chief Scientific Officer & Executive VP

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

NOVOZYMES A/S	7.30%	17 180



ECOLAB INC.	-3.25%	59 752
SIKA AG	2.44%	39 562
GIVAUDAN SA	-0.08%	38 759
EMS-CHEMIE HOLDING AG	-1.47%	22 152
SYMRISE AG	-4.57%	17 040

More Results